Mario Amacker
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Modulation of allergic airways disease employing bio-mimetic nanoparticles with TLR agonists.
Journal: Frontiers in allergy
Published: May 22, 2025
A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge.
Journal: Scientific reports
Published: January 13, 2023
A novel inactivated virus system (InViS) for a fast and inexpensive assessment of viral disintegration.
Journal: Scientific reports
Published: April 25, 2022
Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate.
Journal: Frontiers in bioengineering and biotechnology
Published: February 18, 2022
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
Journal: Frontiers in immunology
Published: October 02, 2021
Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 17, 2020
CD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lung.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: February 20, 2020
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.
Journal: NPJ vaccines
Published: November 20, 2019
Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models.
Journal: NPJ vaccines
Published: October 03, 2019
Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.
Journal: Frontiers in immunology
Published: October 20, 2016
Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitro.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 30, 2016
Last Updated: 09/26/2026